Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Total Liabilities 2020–2022
Elicio Therapeutics Inc. annual total liabilities history from 2020 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Elicio Therapeutics Inc. total liabilities as of December 31, 2022: 13.7M, a 8.38% decrease year-over-year.
- Elicio Therapeutics Inc. total liabilities for 2022 were 13.7M, a 8.38% decrease from 2021.
- Elicio Therapeutics Inc. total liabilities for 2021 were 15.0M, a 89.11% decrease from 2020.
- Elicio Therapeutics Inc. total liabilities for 2020 were 137.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Elicio Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $14 |
| 2021 | $15 |
| 2020 | $138 |
Elicio Therapeutics Inc. Total Liabilities — FAQ
Elicio Therapeutics Inc. (ELTX) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELTX's total liabilities history?
The chart and table above show Elicio Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.